Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2052 ARTÍCULOS , VIENDO DEL 766 AL 780

What contribution can genetics make to predict the risk of Alzheimer's disease?

Schramm C, Wallon D, Nicolas G, Charbonnier C.

Rev Neurol (Paris). 2022 May;178(5):414-421. doi: 10.1016/j.neurol.2022.03.005. Epub 2022 Apr 28.

Cultural Adaptation of the Reducing Disability in Alzheimer's Disease (RDAD) Protocol for an Intervention to Reduce Behavioral and Psychological Symptoms of Dementia in Thailand

Tongsiri S, Levkoff S, Gallagher-Thompson D, Teri L, Hinton L, Wisetpholchai B, Chuengsatiansup K, Sihapark S, Fritz S, Chen H.

J Alzheimers Dis. 2022;87(4):1603-1614. doi: 10.3233/JAD-215253.

PET Imaging in Preclinical Anti-Aβ Drug Development

Syvänen S, Meier SR, Roshanbin S, Xiong M, Faresjö R, Gustavsson T, Bonvicini G, Schlein E, Aguilar X, Julku U, Eriksson J, Sehlin D.

Pharm Res. 2022 Jul;39(7):1481-1496. doi: 10.1007/s11095-022-03277-z. Epub 2022 May 2.

Resources for Enhancing Alzheimer's Caregiver Health in Vietnam (REACH VN): study protocol for a cluster randomized controlled trial to test the efficacy of a family dementia caregiver intervention in Vietnam

Tran D, Nguyen H, Pham T, Nguyen AT, Nguyen HT, Nguyen NB, Nguyen BH, Harvey D, Gitlin L, Hinton L.

Trials. 2022 May 9;23(1):377. doi: 10.1186/s13063-022-06228-6.

IoT-Based Wearable Devices for Patients Suffering from Alzheimer Disease

Salehi W, Gupta G, Bhatia S, Koundal D, Mashat A, Belay A.

Contrast Media Mol Imaging. 2022 Apr 22;2022:3224939. doi: 10.1155/2022/3224939. eCollection 2022.

Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer's Disease Treated with Anti-Amyloid Beta Therapy

Barakos J, Purcell D, Suhy J, Chalkias S, Burkett P, Marsica Grassi C, Castrillo-Viguera C, Rubino I, Vijverberg E.

J Prev Alzheimers Dis. 2022;9(2):211-220. doi: 10.14283/jpad.2022.21.

A Polymorphism Cluster at the 2q12 locus May Predict Response to Piromelatine in Patients with Mild Alzheimer's Disease

Schneider LS, Laudon M, Nir T, Caceres J, Ianniciello G, Capulli M, Zisapel N.

J Prev Alzheimers Dis. 2022;9(2):247-254. doi: 10.14283/jpad.2021.61.

PET Imaging of Dementia: Update 2022

Burkett BJ, Babcock JC, Lowe VJ, Graff-Radford J, Subramaniam RM, Johnson DR.

Clin Nucl Med. 2022 Sep 1;47(9):763-773. doi: 10.1097/RLU.0000000000004251. Epub 2022 May 12.

On Covid-19 and mental health: An observational study on depression, anxiety, and loneliness during the second lockdown in patients with Alzheimer disease

El Haj M, Boutoleau-Bretonnière C, Allain P, Kapogiannis D, Chapelet G, Gallouj K.

Medicine (Baltimore). 2022 May 6;101(18):e29145. doi: 10.1097/MD.0000000000029145.

Recent Advances Towards Diagnosis and Therapeutic Fingerprinting for Alzheimer's Disease

Pradhan LK, Sahoo PK, Chauhan S, Das SK.

J Mol Neurosci. 2022 Jun;72(6):1143-1165. doi: 10.1007/s12031-022-02009-7. Epub 2022 May 12.

Nicotinic Acetylcholine Receptors and Microglia as Therapeutic and Imaging Targets in Alzheimer's Disease

Takata K, Kimura H, Yanagisawa D, Harada K, Nishimura K, Kitamura Y, Shimohama S, Tooyama I.

Molecules. 2022 Apr 27;27(9):2780. doi: 10.3390/molecules27092780.

The Blood-Cerebrospinal Fluid Barrier May Play a Role in Alzheimer Disease Pathogenesis

Chiang GC.

Radiology. 2022 Sep;304(3):646-647. doi: 10.1148/radiol.220740. Epub 2022 May 17.

Electrochemical aptamer-based nanobiosensors for diagnosing Alzheimer's disease: A review

Negahdary M, Angnes L.

Mater Sci Eng C Mater Biol Appl. 2022 Apr;135:112689. doi: 10.1016/j.msec.2022.112689. Epub 2022 Jan 31.

Alzheimer disease neuropathology in a patient previously treated with aducanumab

Plowey ED, Bussiere T, Rajagovindan R, Sebalusky J, Hamann S, von Hehn C, Castrillo-Viguera C, Sandrock A, Budd Haeberlein S, van Dyck CH, Huttner A.

Acta Neuropathol. 2022 Jul;144(1):143-153. doi: 10.1007/s00401-022-02433-4. Epub 2022 May 17.

[Early and differential diagnosis of dementia]

Jacobs AH.

MMW Fortschr Med. 2022 May;164(10):32-39. doi: 10.1007/s15006-022-1027-4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias